According to research report the microbial identification market is expected to reach USD 3.00 Billion by 2022 from USD 2.81 Billion in 2017, at a CAGR of 6.6%. Factors driving the growth of this market include heavy burden of infectious diseases coupled with epidemic and pandemic outbreaks, rising food safety concerns, technological developments in microbial identification techniques, and growing government initiatives and funding supporting microbial identification.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=10702182

The microbial identification market is consolidated in nature due to the presence of a large number of players. The key players in the market are Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), bioMérieux S.A. (France), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Bruker Corporation (US), Shimadzu Corporation (Japan), VWR Corporation (US), Eurofins Scientific S.E. (Luxembourg), GTCR, LLC. (US), QIAGEN N.V. (Netherlands), Liofilchem s.r.l. (Italy), IEH Laboratories & Consulting Group (US), Alcami Corporation (US), Biolog, Inc. (US), Abellon CleanEnergy Limited (India), Alpha Analytical, Inc. (US), NeoGenomics, Inc. (US), Trivitron Healthcare (India), Molzym GmbH & Co. KG (Germany), Dynatec Labs (US), Altogen Labs (US), STERIS plc (UK), and Wickham Laboratories Ltd. (UK).

The key strategy followed by most companies in the microbial identificaiton market are product launches and acquisitions. These strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2017. Some of the leading players who adopted this strategy include Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), bioMérieux S.A. (France), Bruker Corporation (US), and Eurofins Scientific S.E. (Luxembourg).

Becton, Dickinson and Company (US) accounted for the largest share of the microbial identification market in 2016. The company has a wide range of products for microbial identification and focuses on limited applications. BD differentiates its products by branding them and launching new products in the field of clinical diagnostics. Product innovation is the one of the major goals of the company and launched innovative products over the last three years, which are capable of rapidly and accurately identifying microorganisms. For example, in 2016, the company launched the BD Phoenix M50 ID/AST system to identify bacteria and detect antimicrobial resistance.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=10702182

Thermo Fisher Scientific Inc. (US) accounted for the second-largest market share of the microbial identification market in 2016. The company has a broad product portfolio for microbial identification and caters to different applications. Thermo Fisher Scientific launched innovative products to enable the rapid and accurate identification of pathogens from food samples. The company focuses on growing inorganically as it partnered with various companies over the last three years to strengthen its position in the microbial identification market. In 2017, the company partnered with SpeeDx Pty. Ltd. (Australia) with a view to introduce diagnostic tests in the US market.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

newsletter@marketsandmarkets.com